Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 17.23%.However, over the last six months, we can see a stronger performance of -30.90%. Over the last 30 days, the price of RLAY has fallen by 4.77%. And in the last five days, it has surged by 17.23%.
Relay Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $12.14 on 01/10/24, while the lowest price for the same period was registered at $4.01 on 12/31/24.
52-week price history of RLAY Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Relay Therapeutics Inc’s current trading price is -60.21% away from its 52-week high, while its distance from the 52-week low is 20.45%. The stock’s price range during this period has varied between$4.01 and $12.14. The Relay Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.06 million for the day, a figure considerably higher than their average daily volume of 1.92 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Relay Therapeutics Inc (RLAY) has experienced a quarterly decline of -22.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 808.46M and boasts a workforce of 323 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.98, with a change in price of -1.84. Similarly, Relay Therapeutics Inc recorded 2,125,224 in trading volume during the last 100 days, posting a change of -27.59%.
RLAY’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RLAY stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.05.
RLAY Stock Stochastic Average
Relay Therapeutics Inc’s raw stochastic average for the past 50 days is presently 32.93%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 70.69%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 57.18% and 46.26%, respectively.
